References
- Ames, D., & Jowza, M. (2019). Treating opioid dependence: Pain medicine physiology of tolerance and addiction. Clinical Obstetrics and Gynecology, 62(1), 87–97. https://doi.org/10.1097/GRF.0000000000000422
- https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health
- https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm
- https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN160018.pdf
- https://neuroscienceblueprint.nih.gov/neurotherapeutics/blueprint-medtech/blueprint-medtech
- http://neuroscienceblueprint.nih.gov/
- https://grants.nih.gov/grants/guide/pa-files/PAR-21-315.html#_Section_III._Eligibility
- https://www.cimit.org/web/center-for-innovative-neurotech-advancement
- https://neurotechharbor.org/
- https://neuroscienceblueprint.nih.gov/neurotherapeutics/blueprint-medtech/resources
- https://grants.nih.gov/grants/guide/pa-files/PAR-21-315.html
- https://grants.nih.gov/grants/guide/pa-files/PAR-21-282.html
- Jenkins, D. D., Khodaparast, N., O’Leary, G. H., Washburn, S. N., Covalin, A., & Badran, B. W. (2021). Transcutaneous auricular neurostimulation (tAN): A novel adjuvant treatment in neonatal opioid withdrawal syndrome. Frontiers in Human Neuroscience, 15, 648556. https://doi.org/10.3389/fnhum.2021.648556
- Miranda, A., & Taca, A. (2018). Neuromodulation with percutaneous electrical nerve field stimulation is associated with reduction in signs and symptoms of opioid withdrawal: A multisite, retrospective assessment. The American Journal of Drug and Alcohol Abuse, 44(1), 56–63. https://doi.org/10.1080/00952990.2017.1295459
- Qureshi, I. S., Datta-Chaudhuri, T., Tracey, K. J., Pavlov, V. A., & Chen, A. C. H. (2020). Auricular neural stimulation as a new non-invasive treatment for opioid detoxification. Bioelectronic Medicine, 6, 7. https://doi.org/10.1186/s42234-020-00044-6